^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
CANCER:

Adrenal Cortex Carcinoma

23h
Adrenocortical Carcinoma With Right Atrial Extension in a Three-Year-Old Child: A Case Report. (PubMed, Cureus)
Genetic testing revealed a TP53 mutation consistent with Li-Fraumeni syndrome. This case highlights the difficulties in differentiating between adrenocortical carcinoma and CAH in children. The rare presence of intracardiac extension of the tumor increases the challenge in managing these cases.
Journal
|
TP53 (Tumor protein P53)
|
TP53 mutation
4d
Androgen Production in Adrenocortical H295R Cells Is Regulated by Thyroid Hormone T3 Without Reciprocal Thyroid Axis Modulation in Pediatric CAH. (PubMed, J Steroid Biochem Mol Biol)
In conclusion, these findings suggest that THs regulate adrenal androgen production by modulating the activity of key steroidogenic enzymes. This relationship appears to be predominantly unidirectional, as THs influence adrenal steroidogenesis but adrenal androgens do not alter HPT axis function.
Journal
|
AKR1C3 (Aldo-Keto Reductase Family 1 Member C3) • CYP17A1 (Cytochrome P450 Family 17 Subfamily A Member 1)
4d
Targeting matrix metalloproteinase-14 disrupts DNA repair and reduces viability in adrenocortical carcinoma. (PubMed, bioRxiv)
Mechanistically, MMP-14 translocates to the nucleus and binds to chromatin following DNA damage induced by ionizing radiation or cisplatin...These findings reveal a novel nuclear function for MMP-14 in DNA repair and identify MMP-14 as a promising therapeutic target in ACC. Targeting MMP-14 may sensitize ACC tumors to DNA-damaging chemotherapy by impairing the repair of therapy-induced lesions.
Journal
|
CHEK1 (Checkpoint kinase 1) • MMP14 (Matrix Metallopeptidase 14)
|
cisplatin
7d
New trial
7d
A novel 2D and 3D model for primary adrenocortical carcinoma of advanced and metastasized stage co-secreting cortisol, aldosterone, testosterone and 18-oxo/18OH-cortisols. (PubMed, Endocr Relat Cancer)
ZUC-1 spheroids exhibited furthermore an intra-spheroidal heterogenous mix of canonical and non-canonical Wnt pathway activation. We conclude that due to its origin and unique geno- and phenotypes, ZUC-1 represents an intriguing model to further gain basic understanding of adrenal function,the pathogenesis of ACC, but it might be also of interest in context of CAH and PCOS.
Journal
|
CYP11B1 (Cytochrome P450 Family 11 Subfamily B Member 1)
8d
Prevalence and Clinical Characteristics of Lynch Syndrome-associated Adrenocortical Carcinoma. (PubMed, Endocr Relat Cancer)
This study further demonstrates that adrenocortical carcinoma is a Lynch Syndrome-associated cancer and may be associated with high-grade disease. Furthermore, our findings suggest that further research should be pursued to investigate the potential utility of immunotherapy for adrenocortical carcinoma, especially in the presence of microsatellite instability.
Journal • IO biomarker
|
MSI (Microsatellite instability)
12d
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET (clinicaltrials.gov)
P1, N=30, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Recruiting --> Active, not recruiting
Enrollment closed
13d
A Phase 1 Study of [225Ac]-FPI-1434 Injection (clinicaltrials.gov)
P1, N=78, Terminated, Fusion Pharmaceuticals Inc. | N=253 --> 78 | Active, not recruiting --> Terminated; A strategic decision was made to discontinue the study and prioritize other programs within the portfolio. The study was not discontinued due to safety issues or adverse events related to FPI-1434, FPE-1547, or FPI-1175.
Enrollment change • Trial termination • First-in-human
|
IGF1 (Insulin-like growth factor 1)
|
HER-2 negative
|
FPI-1434
13d
Trial completion
13d
Interaction between ENPP1 and homologous recombination deficiency defines distinct pan-cancer signatures: A retrospective observational study. (PubMed, Medicine (Baltimore))
At the individual tumor type level, these global cluster features were further modified to adapt to a tissue-specific microenvironment, manifesting distinct tissue-specific patterns. Collectively, these findings provide a foundation for refining biomarker-driven precision medicine strategies for diverse tumor types.
Observational data • Retrospective data • Journal • Pan tumor
|
HRD (Homologous Recombination Deficiency)
|
HRD
14d
The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancers. (PubMed, Discov Oncol)
Multi-omics analysis suggests that PCMT1 may serve as a potential prognostic biomarker and a novel immunotherapy target for pan-cancer.
Journal • Tumor mutational burden • BRCA Biomarker • IO biomarker
|
TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • BRCA (Breast cancer early onset) • PCM1 (Pericentriolar Material 1)